An observational study in Female Sexual Dysfunction, sponsored by University of Castilla-La Mancha. Completed at 1 site in Spain. Open to female participants aged 18 Years to 60 Years. Per ClinicalTrials.gov, last updated 2025-07-23.
Sponsored by University of Castilla-La Mancha · Observational
Female sexual dysfunctions reach a prevalence of between 38 and 64%, where various factors are involved. One of the sexual dysfunctions that afflict women are those related to pelvic pain and penetration disorders that are closely related to feelings of anguish and anxiety.
Due to the absence of specific, validated and reliable evaluation tools, the purpose of this work is to create an evaluation instrument for women who suffer from this dysfunction, which is self-administered and where the health professional can obtain clear and precise information about his patient. For this, an observational, multicenter study will be carried out in the city of Toledo, Spain, which consists of three large stages; The first will be the creation of domains and items through expert judgment, then a pilot will be carried out to analyze the viability and feasibility and finally the three psychometric properties will be analyzed: validity, confidence and sensitivity to change.
Questionnaires play an important role in practice and research, both as diagnostic clinical tools, measurement of treatment-induced changes, and as research tools when describing a study population and its sexual function. Having a specific, validated, reliable, self-reported tool could facilitate these areas and therefore improve the quality of life of women.
The main objective is:
To build a valid and reliable instrument that is easy to apply for the evaluation of alterations in vaginal penetration and genito-pelvic pain.
An observational, multicenter project is presented that consists of the construction and validation of a Questionnaire in Spanish on Results Perceived by Patients / Health-Related Patient Reported Outcomes.
In stage 1, 10 professionals will be invited to participate, constituting an expert judgment; In stage 2, the pilot will be carried out with 30 women and 2 professionals who can explain the questionnaire to the participants and who can answer questions; In stage 3, a sample size of 10 respondents per item prepared will be required.
130 studies on the registry are indexed under Sexuality; 26 are open to participants now.
This study's enrollment of 150 is above the median of 100 across 47 observational studies indexed under Sexuality.
Browse Sexuality studies →University of Castilla-La Mancha is the lead sponsor of 107 studies on the registry; 26 are open to participants now.
Counted across the registry records on this site, refreshed daily.
This project is aimed at women with complaints of discomfort during vaginal penetration, either during sexual activity, when placing an intravaginal device, or difficulty performing an intracavitary gynecological examination.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Development of domains and items: Through the judgment of 10 experts, the set of items of each domain will be identified. Development of the scale: A pilot will be carried out to guarantee the viability and feasibility of what was created in the previous stage; The questionnaire will be applied to 30. participants. Evaluation of the scale: At this stage, the Questionnaire will be applied to a larger sample: 10 participants for each item create. In the same way as the previous stage, the Female Sexual Function Index will be applied together with the created questionnaire.
✓ Build a valid and reliable instrument that is easy to apply for the evaluation of alterations in vaginal penetration and genito-pelvic pain.
To achieve this goal it is necessary to meet the 3 sub-goals mentioned below.
Time frame: 5 months
Establish domains and items that will form the questionnaire for the evaluation of penetration disorders and genito-pelvic pain.
Through the judgment of 10 experts, the set of elements of each domain will be identified. These professionals will be physiotherapists, gynecologists, midwives and professionals who are experts in creating health scales or questionnaires. Twice as many items should be prepared as it is thought the questionnaire should have. It should be considered that the administration time of the questionnaire does not exceed 10 minutes. The response formats will be of 5 ordered categories where the patient will choose an alternative.
Time frame: 30 days
Evaluate the viability and feasibility in the samples of participants and professionals.
A pilot test will be carried out to guarantee the viability and feasibility of what was created in the previous stage, in addition to ensuring that the questions are significant and understandable; The questionnaire will be applied to a small pre-established sample of participants (n=30) and the answers given will be analyzed to determine the optimal number of items/domains. In the same interview, the Female Sexual Function Index will be applied and a document called "Feasibility of the questionnaire for patients" will be given to them with questions about clarity, comprehensibility and adaptation to their condition. In addition to this, other documents will be delivered to the professionals: one called "Feasibility of the questionnaire for professionals" will be provided to the professionals who supervise the administration of the questionnaires to assess the time it has taken the participants to complete the questionnaire or difficulties that have had.
Time frame: 45 days
Evaluate the valid and reliable of the created questionnaire
At this stage, the Questionnaire is applied to a larger sample: 10 participants for each item created. Statistical tests will be applied to analyze the psychometrics of this instrument. The big aspects to analyze at this stage are reliability, validity and responsiveness.
Time frame: 60 days
Plan to share: No
No publications or documents are linked to this record.
Ran from Jun 2023 to primary completion in Oct 2023, 4 months.
How these figures are worked out, and which studies are left out of them.
This study is completed, as verified in Jul 2025. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
University of Castilla-La Mancha →